⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6971406 | 0.71 | — | — | |
| SCHEMBL11033412 | 0.71 | — | — | |
| SCHEMBL14275887 | 0.71 | — | — | |
| SCHEMBL7668456 | 0.71 | — | — | |
| SCHEMBL576647 | 0.69 | — | — | |
| SCHEMBL9511236 | 0.67 | ALDH1A1 (0.31) | — | |
| SCHEMBL12434602 | 0.65 | — | — | |
| SCHEMBL347863 | 0.65 | — | — | |
| SCHEMBL18132876 | 0.65 | — | — | |
| SCHEMBL576864 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164544-A2 | NOVEL IONIZABLE CATIONIC LIPIDS | SORRENTO THERAPEUTICS, INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| EP-3044216-B1 | NOVEL AND SPECIFIC INHIBITORS OF CYTOCHROME P450 26 RETINOIC ACID HYDROXYLASE | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2022-02-23 | — | — | EP | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |